No-carrier added radiohalogenated nucleosides

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

536 2853, 436804, A61K 3170, A61K 5104, A61K10102, C07H 2102

Patent

active

054223458

ABSTRACT:
A composition comprising no-carrier-added 1-(B-D-arabinofuranosyl)-5-(E)-(2-halogenovinyl)uracil wherein the halogen is radioactive iodine or bromine. This composition can be used to diagnose or treat herpes viral infections.

REFERENCES:
patent: 4211773 (1980-07-01), Lopez et al.
patent: 4386076 (1983-05-01), Machida et al.
patent: 5248771 (1993-09-01), Dougan
S. L. Sacks, et al, Abstract 97, 28th Interscience Conference on Antimicrobial Agents and Chemotherapy (Oct. 1988)--"The Viral Thymidine Kinase (TK)-Dependent Uptake of 1-.beta.-D-arabinofuranosyl-E-5-(2-iodovinyl)uracil (IVaraU) etc." (p. 126.
Moren, et al., J. Labelled Compound and Radiopharmaceulicals, (1994) 35, 205-207.
Samuel et al. Int. J. Appl. Radiat. Isot. 35(11):1049-1052, 1984.
Vorbruggen et al. Appl. Radiat. Isot. 37(4):355-357, 1986.
Robbins et al. J. Med. Chem. 34:2275-2280, 1991.
Bleackley et al. Tetrahedron 32:2745-2747, 1976.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

No-carrier added radiohalogenated nucleosides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with No-carrier added radiohalogenated nucleosides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and No-carrier added radiohalogenated nucleosides will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-987833

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.